S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Sell every Stock except ONE (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Sell every Stock except ONE (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Sell every Stock except ONE (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Denmark says Nord Stream 1 pipelines stop leaking
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Sell every Stock except ONE (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
NASDAQ:CVLB

Conversion Labs - CVLB Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$1.95
$2.19
50-Day Range
$14.48
$30.55
52-Week Range
$0.50
$33.02
Volume
91,627 shs
Average Volume
1.05 million shs
Market Capitalization
$45.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CVLB stock logo

About Conversion Labs (NASDAQ:CVLB) Stock

Conversion Labs, Inc. operates as a direct response healthcare company that provides over the counter products and prescription medications to consumers worldwide. The company's products include Shapiro MD, a shampoo, conditioner, and leave-in-foamer for treating hair loss; iNR Wellness MD, a nutritional supplement for immune and gut support; RexMD for the treatment of cold sores, mental health, and various other medical conditions faced by men; SOSRx, a telemedicine brand that offers prescription medications and over-the-counter emergency preparation supplies for disaster situations, such as flu epidemics, bacterial outbreaks, bioterrorism and water supply failures, and others; and PDFSimpli, a PDF conversion software enables users to convert, edit, and sign PDF documents. It markets and sells its products through advertisements on Facebook, Google, Amazon, and other social media and e-commerce platforms. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was founded in 1994 and is based in New York, New York.

Receive CVLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

CVLB Stock News Headlines

CVLB_old Historical Data
LFMD
LifeMD Inc
Why Conversion Labs Stock Is Trading Higher Today
Conversion Labs reports Q3 prelim
Conversion Lab receives $3.5M from strategic investors
See More Headlines

Receive CVLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Miscellaneous manufacturing industries
Sub-Industry
N/A
Current Symbol
NASDAQ:CVLB
CIK
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

Net Income
$-3,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$12.47 million
Book Value
($0.11) per share

Miscellaneous

Free Float
N/A
Market Cap
$45.67 million
Optionable
Not Optionable
Beta
1.37

Key Executives

  • Mr. Justin Schreiber (Age 38)
    Pres, CEO & Chairman
    Comp: $52k
  • Mr. Juan Manuel Piñeiro Dagnery (Age 34)
    Chief Financial Officer
    Comp: $111.97k
  • Mr. Stefan Galluppi (Age 34)
    CTO & Director
    Comp: $111k
  • Mr. Sean Fitzpatrick (Age 38)
    Pres of LegalSimpli Software LLC
    Comp: $119.27k
  • Mr. Brad Roberts (Age 41)
    Chief Operating Officer
  • Mr. Eric H. Yecies (Age 43)
    Chief Compliance Officer & Gen. Counsel
  • Dr. Joseph V. DiTrolio (Age 70)
    Chief Medical Officer of US & Independent Director
  • Mr. Bryant Patrick Hussey
    Chief Digital Officer
  • Dr. Anthony David Puopolo II
    Chief Medical Officer













CVLB Stock - Frequently Asked Questions

What is Conversion Labs' stock symbol?

Conversion Labs trades on the NASDAQ under the ticker symbol "CVLB."

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $1.97.

How much money does Conversion Labs make?

Conversion Labs (NASDAQ:CVLB) has a market capitalization of $45.67 million and generates $12.47 million in revenue each year.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.conversionlabs.com. The company can be reached via phone at (866) 351-5907 or via email at info@conversionlabs.com.

This page (NASDAQ:CVLB) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.